To the Editor:
The reversible lipase inhibitor orlistat is a safe and effective weight-reducing agent that decreases intestinal fat absorption. The most frequently reported side effects of orlistat have been mild to moderate gastrointestinal tract adverse events including fatty/oily stools, abdominal pain, and fecal urgency. 1 However, we here would like to describe a recent case of acute hepatic injury caused by orlistat use.
A 15-year-old Thai woman without remarkable medical history had taken orlistat (120 mg three times daily) for 7 days due to concerns of obesity. One week later, the patient was admitted to an emergency hospital with abdominal pain, malaise, nausea, and diarrhea, and was transferred to our hospital the following day. She had no toxic habits and denied taking any other medications or herbal remedies. She was alert, her body temperature was 37.5°C, BMI was 20.0%, white blood cell count was 2,870/µl, eosinophils were 7%, and platelet count was10. 
